The COVID-19 patients at the acute disease time-point and the sub-cohort with blood samples available at all three follow-up time-points (M5, M12, and M20) did not differ in their distribution of sex (54% and 51% female, respectively), age (47% and 49% at an age ≥60 years at acute disease onset), severity of disease (38% and 39% with severe/critical disease), pre-existing medical conditions (53% with ≥1 condition for both), or CRP level during acute disease (75% and 74% with >5 mg/L) (Table 1). This evidence concerns the gene CRP and COVID-19.